| Literature DB >> 33672150 |
Akihiro Mori1, Soichiro Murata1,2, Nao Tashiro1, Tomomi Tadokoro1, Satoshi Okamoto1, Ryo Otsuka3, Haruka Wada3, Tomoki Murata3, Takeshi Takahashi4, Ken-Ichiro Seino3, Hideki Taniguchi1,2.
Abstract
Humanized mouse models have contributed significantly to human immunology research. In transplant immunity, human immune cell responses to donor grafts have not been reproduced in a humanized animal model. To elicit human T-cell immune responses, we generated immune-compromised nonobese diabetic/Shi-scid, IL-2RγKO Jic (NOG) with a homozygous expression of human leukocyte antigen (HLA) class I heavy chain (NOG-HLA-A2Tg) mice. After the transplantation of HLA-A2 human hematopoietic stem cells into NOG-HLA-A2Tg, we succeeded in achieving alloimmune responses after the HLA-mismatched human-induced pluripotent stem cell (hiPSC)-derived liver-like tissue transplantation. This immune response was inhibited by administering tacrolimus. In this model, we reproduced allograft rejection after the human iPSC-derived liver-like tissue transplantation. Human tissue transplantation on the humanized mouse liver surface is a good model that can predict T-cell-mediated cellular rejection that may occur when organ transplantation is performed.Entities:
Keywords: allograft rejection; human iPS cell; humanized mouse; liver bud
Year: 2021 PMID: 33672150 DOI: 10.3390/cells10020476
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600